Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis-Reference-Cited by-同舟云学术

Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis

Published:2022-02 Issue:2 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Ding Yufeng¹,Chi Honggang²,Shao Jialiang³,Shi Tiezhu³,Yu Hua¹,Wang Xiang³,Wang Xiongjun¹^ORCID

Affiliation:

1. School of Life Sciences Guangzhou University Guangzhou China

2. Department of Traditional Chinese Medicine The First Dongguan Affiliated Hospital of Guangdong Medical University Dongguan China

3. Department of Urology Shanghai General Hospital Shanghai Jiaotong University Shanghai China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.676

Reference59 articles.

1. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer

2. Acetylation-Dependent Signal Transduction for Type I Interferon Receptor

3. The AMPA Receptor Code of Synaptic Plasticity

4. Post-translational modification of the androgen receptor

5. Post-translational modification of pregnane x receptor

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of protein post-translational modifications in prostate cancer;PeerJ;2024-08-12

2. Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy;Bioorganic Chemistry;2024-02

3. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04

4. Acetyl-CoA metabolism as a therapeutic target for cancer;Biomedicine & Pharmacotherapy;2023-12

5. Emerging role of GCN5 in human diseases and its therapeutic potential;Biomedicine & Pharmacotherapy;2023-09